Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Verschuuren, J.J.G.M.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(81 - 100 of 123)

Pages

Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials
Geographical Distribution of Myasthenia Gravis in Northern Europe - Results from a Population-Based Study from Two Countries
Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations
Evaluation of skeletal muscle DTI in patients with duchenne muscular dystrophy
Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants
Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models
An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts
Prognostic factors for exacerbations and emergency treatments in myasthenia gravis
Studying the role of dystrophin-associated proteins in influencing Becker muscular dystrophy disease severity
Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2
Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes
Age-Related Longitudinal Changes in Metabolic Energy Expenditure during Walking in Boys with Duchenne Muscular Dystrophy
MMP-9 serum levels increase over time in Duchenne muscular dystrophy patients and decrease upon treatment with drisapersen
Temporalis Muscle Hypertrophy and Reduced Skull Eccentricity in Duchenne Muscular Dystrophy
Abnormalities in T cell differentiation in patients with the Lambert-Eaton myasthenic syndrome
Population-based incidence and prevalence of facioscapulohumeral dystrophy
Fibronectin is a serum biomarker for Duchenne muscular dystrophy
Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy
Treatment options for Lambert-Eaton myasthenic syndrome
Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants

Pages